Influenza, Human  >>  Agriflu (trivalent influenza virus vaccine)  >>  Phase 4
Welcome,         Profile    Billing    Logout  

3 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Agriflu (trivalent influenza virus vaccine) / CSL Behring
NCT00560066 / 2007-002872-32: Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions

Completed
4
1398
Europe
Cell-derived influenza vaccine, Egg-derived influenza vaccine
Novartis Vaccines
Seasonal Influenza, Vaccine
07/08
07/08
NCT01368796: Comparison of 4 Influenza Vaccines in Seniors

Completed
4
953
Canada
Agriflu, Fluad, Intanza, Vaxigrip
University of British Columbia, PHAC/CIHR Influenza Research Network
Influenza Vaccine
12/11
05/12
NCT01867021 / 2012-003740-74: Immunogenicity, Safety and Tolerability of a Trivalent Subunit Inactivated Vaccine in Healthy Subjects 50 Years and Above

Completed
4
2902
Europe, RoW
Fluvirin(TIVf), Trivalent Influenza Virus Vaccine (purified surface antigen, inactivated, egg-derived), Agriflu (TIV)
Novartis, Novartis Vaccines
Influenza
12/13
12/13

Download Options